Site MapPagesHomeBrain Tumor StoriesE-NewsletterInfigratinib in Recurrent Glioblastoma PatientsIt’s personalIvy BlogIvy Center RetreatIvy Center RetreatPhysiciansSupportThe ChallengeCurrent Standard of CareConventional Clinical TrialsPhase 0 Clinical TrialsWhy Phase 0 Trials?What We TreatHigh-Grade Glioma and Glioblastoma Clinical TrialsClinical Trials for Brain Metastases TreatmentClinical Trials for Recurrent MeningiomaRecurrent Anaplastic Ependymoma Clinical TrialsRecurrent Craniopharyngioma Clinical TrialsClinical Trials for Pineal-Region TumorsCurrent TrialsPatientsPatient StoriesWhat to ExpectPlan Your VisitCOVID-19 InformationLodgingTransportationPatient SupportFAQsResearchScientific CoresLabsMehta LaboratoryTovmasyan LaboratoryTien LaboratoryMirzadeh LaboratoryCertificationsPreclinical WorkIndustry CollaborationPublished ResearchAboutTeamAdministrationBusiness OperationsClinical OperationsCommunicationsPreclinical and Translational ScienceBarrow Neurological InstituteThe Ben and Catherine Ivy FoundationNewsroomEventsCareersContact Us
